Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Talis Biomedical (TLIS)

Talis Biomedical Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TLIS
DateTimeSourceHeadlineSymbolCompany
08/05/202413:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TLISTalis Biomedical Corporation
26/01/202421:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
14/11/202313:00GlobeNewswire Inc.Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve CashNASDAQ:TLISTalis Biomedical Corporation
01/09/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
10/08/202322:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TLISTalis Biomedical Corporation
10/08/202321:46Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TLISTalis Biomedical Corporation
10/08/202321:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
10/08/202321:05GlobeNewswire Inc.Talis Biomedical Announces Second Quarter 2023 Financial Results and Business UpdateNASDAQ:TLISTalis Biomedical Corporation
03/08/202313:00GlobeNewswire Inc.Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023NASDAQ:TLISTalis Biomedical Corporation
02/08/202313:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
02/08/202313:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
02/08/202313:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
02/08/202313:00GlobeNewswire Inc.Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)NASDAQ:TLISTalis Biomedical Corporation
27/07/202313:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
27/07/202313:00GlobeNewswire Inc.New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product MenuNASDAQ:TLISTalis Biomedical Corporation
24/07/202313:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
24/07/202313:00GlobeNewswire Inc.Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:TLISTalis Biomedical Corporation
18/07/202322:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
05/07/202313:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
05/07/202313:00GlobeNewswire Inc.Talis Biomedical Announces 1-for-15 Reverse Stock SplitNASDAQ:TLISTalis Biomedical Corporation
13/06/202321:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
12/06/202322:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
12/06/202322:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
12/06/202322:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
12/06/202322:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
12/06/202322:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
09/06/202321:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TLISTalis Biomedical Corporation
23/05/202313:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TLISTalis Biomedical Corporation
23/05/202313:00GlobeNewswire Inc.Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent DirectorNASDAQ:TLISTalis Biomedical Corporation
11/05/202321:38Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TLISTalis Biomedical Corporation
 Showing the most relevant articles for your search:NASDAQ:TLIS

Your Recent History